Kawamoto Ryuichi, Kikuchi Asuka, Ninomiya Daisuke
Department of Community Medicine, Ehime University Graduate School of Medicine, Seiyo, JPN.
Department of Community Medicine, Ehime University Graduate School of Medicine, Toon, JPN.
Cureus. 2024 Aug 30;16(8):e68247. doi: 10.7759/cureus.68247. eCollection 2024 Aug.
Introduction In this investigation, the focus was on exploring the connection between serum gamma-glutamyl transferase (GGT), a vital element that influences health and mortality in relation to aging, and all-cause mortality. The study was conducted using a follow-up approach at eight- and 20-year intervals. Methods The study involved 1,101 female participants, with an average age of 69 years (± 9), and 916 male participants, with an average age of 67 years (± 11), who were all diagnosed with hypertension. These individuals were drawn from the Nomura cohort study, which consisted of two separate cohorts: the initial cohort established in 2002 and the subsequent cohort in 2014. We used a Cox proportional hazards model to calculate the hazard ratios (HRs), adjusted for multiple variables, for mortality risk from the initial health examination until the conclusion of the follow-up periods. Results The study followed the participants for a median period of 13.9 years (interquartile range: 8.5-20.2 years). During this follow-up period, 716 deaths were recorded in this population (360 in men and 356 in women), resulting in a mortality rate of 25.5 deaths per 1,000 person-years. Male participants categorized with serum GGT levels ranging from 42 to 86 IU/L showed a 64% increased risk of all-cause mortality (HR: 1.64; 95% confidence interval (CI): 1.11-2.40), while those with GGT levels of 87 IU/L or higher exhibited a 93% elevated risk (HR: 1.93; 95% CI: 1.18-3.16) compared to individuals with GGT levels below 19 IU/L. The association between higher GGT levels and increased all-cause mortality was more evident in men than in women, with a significant interaction between gender and baseline serum GGT (p = 0.020). Conclusions Our findings suggest a notable correlation between irregular GGT levels and the overall mortality rate among Japanese individuals with hypertension living in community settings. Notably, especially in older males, GGT activity turns out to be a critical biomarker for predicting long-term survival.
引言 在本调查中,重点是探索血清γ-谷氨酰转移酶(GGT)这一影响衰老相关健康和死亡率的关键因素与全因死亡率之间的联系。该研究采用了每隔8年和20年进行一次随访的方法。
方法 该研究纳入了1101名平均年龄为69岁(±9岁)的女性参与者和916名平均年龄为67岁(±11岁)的男性参与者,他们均被诊断患有高血压。这些个体来自野村队列研究,该研究由两个独立的队列组成:2002年建立的初始队列和2014年的后续队列。我们使用Cox比例风险模型计算从初始健康检查到随访期结束的死亡风险的风险比(HRs),并对多个变量进行了调整。
结果 该研究对参与者进行了中位数为13.9年的随访(四分位间距:8.5 - 20.2年)。在该随访期内,该人群记录了716例死亡(男性360例,女性356例),死亡率为每1000人年25.5例死亡。血清GGT水平在42至86 IU/L之间的男性参与者全因死亡率风险增加了64%(HR:1.64;95%置信区间(CI):1.11 - 2.40),而GGT水平在87 IU/L或更高的参与者与GGT水平低于19 IU/L的个体相比,风险升高了93%(HR:1.93;95% CI:1.18 - 3.16)。较高的GGT水平与全因死亡率增加之间的关联在男性中比在女性中更明显,性别与基线血清GGT之间存在显著交互作用(p = 0.020)。
结论 我们的研究结果表明,在社区环境中生活的患有高血压的日本个体中,GGT水平异常与总体死亡率之间存在显著相关性。值得注意的是,尤其是在老年男性中,GGT活性成为预测长期生存的关键生物标志物。